Back

Reach out

Please select an option

Please select an option

Please enter a valid email address

Please complete this field

400 characters limit

Please complete this field

400 characters limit

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

News

News & Stories

News

Orchard Therapeutics presents additional positive data regarding MPS-IH 

News

New hope for Niemann-Pick Disease Type C treatment as Bloomsbury Genetic Therapies receives Orphan Drug Designations

News

UCLB spinout Orchard Therapeutics to be acquired by Kyowa Kirin for $477m

News

Bramble Energy reveals world’s ‘lowest cost’ hydrogen fuel cell

Web

Business Insider: Bramble named among the 23 startups inventing moonshot technology that are set to take off

Web

Bloomsbury GTX presents new Preclinical Data on CNS Programs at the European Society of Gene & Cell Therapy (“ESGCT”) Congress 2022

News

The Times names UCL University of the Year 2024

News

UCL partner Apollo Therapeutics receives $226.5m to translate medical research into treatments

News

Phasecraft raises £13m, led by Playground Global, to become the first to reach practical quantum advantage

News

UCL backed tumour-busting cancer therapy cleared for clinical trials

News

Investor Q&A: Barny Cox

News

Treatment for infantile neuroaxonal dystrophy a step closer as Bloomsbury Genetic Therapies receives Orphan Drug Designations  

News

New Alzheimer’s hope as UCLB spinout AstronauTx closes $61m Series A financing

Let’s Talk

UCLTF offers investment throughout the commercialisation journey. We fund proof-of-concept and development projects, and support founding teams with company formation.

Learn more